Welcome Guest

 
Herbal products: Hoodia ChaserAvatrimDietrine

Colitis


1: ViroPharma Incorporated Reports Second Quarter 2010 Financial Results
ViroPharma Incorporated reported today its financial results for the second quarter ended June 30, 2010. In the second quarter of 2010 we: -- Achieved a record $109 million in net product sales; -- Increased Cinryze net sales by 58 percent over prior year's second quarter to $40 million; -- Attained Non-GAAP adjusted net income of $36 million, representing 38 percent growth over the prior year second quarter; GAAP net income reached $29 million; -- Delivered record positive cash flows from operations of $54 million; -- Improved working capital to $465 million as of June 30, 2010, including cash, cash equivalents and short-term investments of $406 million; -- Submitted the Cinryze industrial scale manufacturing Prior Approval Supplement (PAS) to the U.S.

2: Tremelimumab monotherapy ineffective for advanced colorectal cancer
NEW YORK (Reuters Health) - Monotherapy with tremelimumab, an anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody (anti-CTLA4), had no clinically meaningful impact on refractory metastatic colorectal cancer in a phase II trial. But we're "just (at) the beginning in the development of immune-based approaches" such as anti-CTLA4 agents, said lead author Dr.

3: Lisa's road to Ironman: Part 4
Dr. David Wikenheiser, Naturopathic Physician and Dr. Luba Nowek, BS, DC (Hons) have teamed together with Lisa Redl to get her in top form for the Ironman Triathlon at last minutes notice. This week they fix an old injury and try to get her diet right after being diagnosed with Celiac. The goal of C4 Canada is to provide information to anyone dealing with an inflammatory bowel condition such as IBS or Colitis, a genetic disorder such as Celiac or Chrohn's Disease, or other conditions such as parasitic, fungal or yeast infections.

4: Colon cleanse an easy way of weight loss
Have you often faced a problem of constipation , Hemorrhoids, Appendicitis, Colitis and irritable bowl syndrome. The main reason behind all these problems are your poor diet and a bad life style. These are the problems related to Colon.If we don What is Colon: Colon is a part of our body.

5: Study Recommends Hand-assisted Subtotal and Total Colectomies for Extensive ...
Hand-assisted laparoscopic surgery (HALS) has demonstrated its value as a versatile therapeutic alternative to laparoscopic (LAP) colorectal resection for complex intestinal diseases such as ulcerative colitis and diverticulitis. However, its efficacy in patients undergoing technically demanding subtotal or total colectomy for Crohn's colitis has not been ascertained as yet.

6: More evidence ties acne drug to bowel disease
NEW YORK (Reuters Health) - Adding to evidence that the acne drug isotretinoin may lead to bowel disease in some users, a new study finds that patients on the medication were four times more likely than non-users to develop ulcerative colitis within a year. HealthReporting in the American Journal of Gastroenterology, researchers say that the risk of any one isotretinoin user developing ulcerative colitis is "likely quite small." However, the findings do strengthen the evidence of a cause-and-effect relationship between the acne drug and inflammatory bowel disease (IBD) -- a group of digestive disorders that includes ulcerative colitis and Crohn's disease.

7: Personal training without the boot camp intimidation
Michelle Dumovich strives to provide each and every one of her clients. Operating as the M.D. Complete Fitness Pilates and Wellness Center out of her Trinity-area office in the Bradford Professional Plaza, 2200 Seven Springs Boulevard, Suites 113 and 114, Dumovich offers individuals of all walks the type of training that gets results without overbearing anxieties that turn many off.

8: Let Me Introduce You To Eosinophilic Enteropathy
tonight while going through blogtalk radio causing trouble, i stumbled upon a show there about the paranormal and listened to this one guy by the name of Mike Dionne talk about his experiences on the USS Salem the same place that TAPS investigated during this last season of Ghost Hunters. anyways it was great and then he went on to talk about something else that completely floored me and i felt the need to share it and help spread the word on it.

9: Kickboxing or BOSU combinations with strength training. ...
Submissions for Community Calendar are required 14 days preceding the date of publication. Send to: Niles Managing Editor, Pioneer Press, 3701 W. Lake Ave., Glenview IL 60026. Information may be faxed to (847) 486-7495 or e-mailed to mbottari@pioneerlocal.com. Tuesdays, Wednesdays (every week) - Employment counseling, by appointment.

10: Bud Withers WSU safety, Bellevue grad deals with medical issue
Washington State safety Eric Block - "a wonderful kid," in coach Paul Wulff's words - missed the last spring practices of 2008 and then was diagnosed with ulcerative colitis, a disease of the large intestine PULLMAN - He was always so good at hiding it. Eric Block would take the snap in Bellevue High's Wing-T offense and handle the ball like a veteran blackjack dealer.

11: Patient Resource Center, 8820 W. Dempster Street, Niles ...
Submissions for Community Calendar are required 14 days preceding the date of publication. Send to: Niles Managing Editor, Pioneer Press, 3701 W. Lake Ave., Glenview IL 60026. Information may be faxed to (847) 486-7495 or e-mailed to mbottari@pioneerlocal.com. The Center of Concern, 1580 N.

12: BCIR Ileostomy Expert, Dr. Don J. Schiller, to Speak at 24th ...
Recognized expert in BCIR surgery for continent and conventional Ileostomy patients, Don J. Schiller, MD, FACS, will deliver an address on August 21, 2009 at the 24th Annual Education Symposium of the Quality Life Association (QLA). (PRWEB) June 5, 2009 -- Don J. Schiller, MD, FACS, a recognized expert in BCIR surgery for continent and conventional ileostomy patients, will deliver an address on August 21, 2009 at the 24th Annual Education Symposium of the Quality Life Association (more information on QLA at http://www.ileostomy-surgery.com).

13: Is a Well-Intentioned Drive to Include Probiotics Inadvertently ...
Is a Well-Intentioned Drive to Include Probiotics Inadvertently Contributing to Obesity, Cholesterol and Other Health Problems? Jackson GI Medical releases new analysis suggesting that nutritionally-neutral supplements may be a better choice than food products "enhanced" with prebiotics and probiotics.

14: Ulcerative Colitis Disease Flares Treated by Increasing Medication ...
By Ed Susman CHICAGO -- May 31, 2009 -- Researchers said here at Digestive Disease Week (DDW) 2009 that patients who described themselves as suffering from moderate to severe ulcerative colitis usually have their medications increased and/or have immunomodulators added to their treatment therapy in response to disease flares.

15: Crohn's and colitis manifesto launched
Crohn's and colitis manifesto launched Posted: Tue 12/05/2009 by Joanne McCarthy A new patient manifesto created by young people living with inflammatory bowel disease (IBD) has been launched. Young people with IBD are calling for greater public awareness of their condition, which will lead to earlier recognition of symptoms, earlier diagnosis and better disease management.

16: Ulcerative Colitis Treatment
Those with suspicious symptoms should get a lactose breath hydrogen test. If lactose is restricted, calcium may need to be supplemented to avoid bone loss. Patients with abdominal cramping or diarrhea may find relief or a reduction in symptoms by avoiding fresh fruits and vegetables, caffeine, carbonated drinks and sorbitol-containing foods.

17: Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128 ...
Start of trial triggers $10 million milestone payment to Pharmasset PRINCETON, N.J. , April 24 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) and Roche (Roche SWX: RO, ROG; Pink Sheets: RHHBY) today announced that the first patient has been dosed in a Phase IIb study of R7128, the nucleoside polymerase inhibitor most advanced in development for the treatment of chronic hepatitis C (HCV).

18: The gel of this plant has many uses including creams and lotions ...
Many grow the Aloe Vera plant as a house plant. It does not thrive in cold weather, but it will inside your home. Although, some enjoy the Aloe Vera plant as a decorative that is the very least of its usage. For thousands of years, people around the globe have used the Aloe Vera plant as a supplier of a useful gel.

19: Drugless Pain Solutions
Americans take an inordinate amount of medication to reduce pain and inflammation, most notably acetaminophen, aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. In fact, it is estimated that each year, Americans purchase literally billions of over-the-counter (OTC) anti-inflammatory drugs.

20: FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for ...
COLLEGEVILLE, Pa., March 24, 2009 /PRNewswire-FirstCall via COMTEX/ ----Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) approved TYGACIL(R) (tigecycline), for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.

21: azathioprine, Imuran, Azasan
Font Size A A A 1 2 Next ' azathioprine Index Glossary Pharmacy Author: Annette O. Gbemudu, PharmD, MBA Medical and Pharmacy Editor: Jay W. Marks, MD GENERIC NAME: azathioprine BRAND NAME: Imuran, Azasan DRUG CLASS AND MECHANISM: Azathioprine is some immunosuppressant, that is, a mix with drugs that is used to repress the immune a whole.

22: Early, regular screening best for detecting cancer
March is National Colorectal Cancer Awareness Month. Colorectal cancer - cancer of the colon and rectum - is the third most common cancer found in men and woman and the second leading cause of cancer deaths in the United States. The latter is a sad statistic, when you consider that colorectal cancer is preventable and, when detected early, up to 90 percent curable.

23: FDA Grants Orphan Drug Designation for EUR-1073
PHILADELPHIA, PA - Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for EUR-1073 (beclomethasone diproprionate) in pediatric patients.


Page 1 of 1
[1]